Evidence map›Paper›PMID 36643030›Full record

ArticleJournal of clinical and translational hepatology2023

Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI.

Han-Dan Zhang, Xiao-Ming Li, Yu-Han Zhang, Fang Hu, Liang Tan, Fang Wang, Yang Jing, Da-Jing Guo, Yang Xu, Xian-Ling Hu and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical and translational hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Han-Dan ZhangDepartment of Radiology, Southwest Hospital, Third Military Medical University (Army Military Medical University), Chongqing, China.
Xiao-Ming LiDepartment of Radiology, Southwest Hospital, Third Military Medical University (Army Military Medical University), Chongqing, China.
Yu-Han ZhangDepartment of Radiology, Southwest Hospital, Third Military Medical University (Army Military Medical University), Chongqing, China.
Fang HuDepartment of Radiology, Southwest Hospital, Third Military Medical University (Army Military Medical University), Chongqing, China.
Liang TanDepartment of Neurosurgery, Third Military Medical University (Army Military Medical University), Chongqing, China.
Fang WangDepartment of Market, Huiying Medical Technology Co., Ltd, Beijing, China.
Yang JingDepartment of Market, Huiying Medical Technology Co., Ltd, Beijing, China.
Da-Jing GuoDepartment of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yang XuDepartment of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xian-Ling HuCommunication Sergeant School, Army Engineering University of PLA, Chongqing, China.
Chen LiuDepartment of Radiology, Southwest Hospital, Third Military Medical University (Army Military Medical University), Chongqing, China.ORCID https://orcid.org/0000-0001-5149-2496
Jian WangDepartment of Radiology, Southwest Hospital, Third Military Medical University (Army Military Medical University), Chongqing, China.ORCID https://orcid.org/0000-0003-1210-0837
Army Medical University · CNDalian Medical University · CNHua Medicine (China) · CNPLA Army Engineering University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: The study established and compared the efficacy of the clinicoradiological model, radiomics model and clinicoradiological-radiomics hybrid model in predicting the microvascular invasion (MVI) of hepatocellular carcinoma (HCC) using gadolinium ethoxybenzyl diethylene triaminepentaacetic acid (Gd-EOB-DTPA) enhanced MRI. Methods: This was a study that enrolled 602 HCC patients from two institutions. Least absolute shrinkage and selection operator (Lasso) method was used to screen for the most important clinicoradiological and radiomics features that predict MVI pre-operatively. Three machine learning algorithms were used to establish the clinicoradiological, radiomics, and clinicoradiological-radiomics hybrid models. Area under the curve (AUC) of receiver operating characteristic (ROC) curves and Delong's test were used to compare and quantify the predictive performance of the models. Results: The AUCs of the clinicoradiological model in training and validation cohorts were 0.793 and 0.701, respectively. The radiomics signature of arterial phase (AP) images alone achieved satisfying predictive efficacy for MVI, with AUCs of 0.671 and 0.643 in training and validation cohort, respectively. The combination of clinicoradiological factors and fusion radiomics signature of AP and VP images achieved AUCs of 0.824 and 0.801 in training and validation cohorts, 0.812 and 0.805 in prospective validation and external validation cohorts, respectively. The hybrid model provided the best prediction results. The results of the Delong test revealed that there were statistically significant differences among the clinicoradiological-radiomics hybrid model, clinicoradiological model, and radiomics model ( Conclusions: The combination of clinicoradiological factors and fusion radiomics signature of AP and VP images based on Gd-EOB-DTPA-enhanced MRI can effectively predict MVI.

Indexed as

Gd-EOB-DTPAHepatocellular carcinomaMicrovascular invasionRadiomics

Identifiers

PMID36643030
PMCPMC9817048
OpenAlexW4229452795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.